BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 801216)

  • 21. Humoral antibodies in canine renal allotransplantation. A preliminary observation by tissue culture technic.
    Sekiguchi M; Matsukura M; Kurosawa T; Endo S
    Jpn J Exp Med; 1971 Aug; 41(4):375-80. PubMed ID: 4936585
    [No Abstract]   [Full Text] [Related]  

  • 22. Recipient presensitization: a critical survey.
    Descamps B; Kreis H
    Adv Nephrol Necker Hosp; 1976; 6():443-61. PubMed ID: 828454
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal transplantation between histocompatible donor-recipient pairs.
    Seigler HF; Stickel DL; Gunnells JC; McCoy R; Ward FE; Anderson EE; Amos DB
    Transplant Proc; 1972 Dec; 4(4):439-46. PubMed ID: 4264867
    [No Abstract]   [Full Text] [Related]  

  • 24. Hyperimmune F(ab') 2 antibody: role in canine hyperacute renal allograft rejection.
    Habal MB; Kobayashi K; Busch GJ; Birtch AG
    J Surg Res; 1972 Nov; 13(5):228-31. PubMed ID: 4117988
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of immunologic donor pretreatment on survival of perfused canine renal allografts.
    Pechan W; Novick AC; Stowe N; Magnusson M; Straffon RA
    Invest Urol; 1980 Jul; 18(1):74-6. PubMed ID: 6997225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OKT4A monoclonal antibody immunosuppression of cynomolgus renal allograft recipients.
    Cosimi AB; Delmonico FL; Wright JK; Wee SL; Preffer FI; Bedle M; Colvin RB
    Transplant Proc; 1991 Feb; 23(1 Pt 1):501-3. PubMed ID: 1990600
    [No Abstract]   [Full Text] [Related]  

  • 27. Active enhancement of canine renal allografts.
    Holl-Allen RT; Rippin A; Scharli A; Simonian S; Busch GJ; Wilson RE; Baddeley RM
    Br J Surg; 1970 Nov; 57(11):852. PubMed ID: 4921414
    [No Abstract]   [Full Text] [Related]  

  • 28. Correlation of platelet aggregation in canine renal allotransplants with serum cytotoxic antibody following treatment with azathioprine.
    Lowenhaupt RW; Nathan P; Menefee MG
    Transplant Proc; 1971 Mar; 3(1):453-6. PubMed ID: 4937917
    [No Abstract]   [Full Text] [Related]  

  • 29. Characterization of protective anti-Fab autoantibodies in kidney graft recipients.
    Süsal C; Groth J; Tanzi-Fetta RF; Kirste G; Doerr C; Terness P; May G; Staehler G; Opelz G
    Transplant Proc; 1992 Dec; 24(6):2523-6. PubMed ID: 1465853
    [No Abstract]   [Full Text] [Related]  

  • 30. Biopsy features of early acute rejection in cadaveric renal grafts.
    Kincaid-Smith P; McKenzie IF; Morris PJ; Marshall VC
    Transplant Proc; 1969 Mar; 1(1):287-9. PubMed ID: 4944228
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunologic properties of placental eluates.
    Revillard JP; Brochier J; Robert M; Bonneau M; Traeger J
    Transplant Proc; 1976 Jun; 8(2):275-9. PubMed ID: 820023
    [No Abstract]   [Full Text] [Related]  

  • 32. The riddle of kidney graft enhancement.
    Batchelor JR
    Transplantation; 1978 Sep; 26(3):139-41. PubMed ID: 100913
    [No Abstract]   [Full Text] [Related]  

  • 33. Multiple specificities of B lymphocyte-reactive antibodies and their significance in renal allograft survival.
    Rhodes CL; Goldman MH; Mendez-Picon G; Lee HM; Mohanakumar T
    Transplant Proc; 1984 Dec; 16(6):1425-6. PubMed ID: 6390841
    [No Abstract]   [Full Text] [Related]  

  • 34. Ia-positive donor-specific bone marrow cells prolong renal allografts in dogs treated with fractionated lymphoid irradiation.
    Watanabe K; Taniai S; Sato K; Sonoda K; Masaki Y; Takahara H; Matsubayashi T; Kashiwagi N
    Transplant Proc; 1987 Feb; 19(1 Pt 1):632-4. PubMed ID: 2978927
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cold lymphocytotoxins in kidney graft recipients].
    Roy R; Robert M; Lachance JG; Daguillard F
    Union Med Can; 1977 Mar; 106(3):297-300. PubMed ID: 324066
    [No Abstract]   [Full Text] [Related]  

  • 36. Variant forms of arteritis in human renal allografts.
    Busch GJ; Garovoy MR; Tilney NL
    Transplant Proc; 1979 Mar; 11(1):100-3. PubMed ID: 377602
    [No Abstract]   [Full Text] [Related]  

  • 37. Cell-mediated immunity and blocking antibodies to renal allografts.
    Hellström I; Hellström KE
    Transplant Proc; 1972 Sep; 4(3):369-71. PubMed ID: 4562764
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful renal allografts in recipients with a positive standard, DTE negative cross-match.
    Barger BO; Shroyer TW; Hudson SL; Deierhoi MH; Barber WH; Curtis JJ; Julian BA; Luke RG; Diethelm AG
    Transplant Proc; 1989 Feb; 21(1 Pt 1):746-7. PubMed ID: 2650253
    [No Abstract]   [Full Text] [Related]  

  • 39. Presence of IgG HLA antibodies in patients with long-surviving renal allografts.
    Norman PJ; Harmer AW; Koffman CG; Vaughan RW
    Transplant Proc; 1995 Feb; 27(1):999-1000. PubMed ID: 7879260
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhanced survival of canine renal allografts of ALS- treated dogs given bone marrow.
    Caridis DT; Liegeois A; Barrett I; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):671-4. PubMed ID: 4572126
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.